Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Infect Drug Resist ; 17: 2189-2198, 2024.
Article in English | MEDLINE | ID: mdl-38835493

ABSTRACT

Objective: In this paper, we analyzed the clinical data of patients with meningoencephalitis caused by Streptococcus intermedius to understand better the clinical characteristics of the disease and recommend auxiliary diagnostic mode as well as treatment experience. Methods: We reviewed the clinical data of two patients admitted to our department in 2019 with meningoencephalitis caused by S. intermedius. Results: Two female patients were examined, one of whom had a history of radiotherapy for nasopharyngeal carcinoma while the other had no underlying disease. These two patients were admitted with symptoms of meningoencephalitis. Cerebrospinal fluid examinations revealed elevated levels of leukocytes and protein. After treatment with meropenem, the condition improved for a brief time, but then worsened with a decline in mental status and limb movement. Blood and cerebrospinal fluid cultures demonstrated the absence of pathogenic bacteria, while genome sequencing of cerebrospinal fluids revealed the presence of S. intermedius. Cranial magnetic resonance imaging revealed multiple cerebral abscesses (CAs). After coadministration of linezolid as an anti-infective, clinical symptoms gradually improved, and the CAs shrank on follow-up imaging. The condition exhibited a pattern of improvement-deterioration-improvement. Conclusion: Meningoencephalitis caused by S. intermedius is complex and prone to fluctuation and formation of multiple CAs. The definitive clinical diagnosis of this disease can be aided by genome sequencing technology, and early clarification of the etiology combined with the use of potent antibiotics is effective.

2.
Aesthet Surg J ; 44(6): NP357-NP364, 2024 May 15.
Article in English | MEDLINE | ID: mdl-38340328

ABSTRACT

BACKGROUND: Use of local anesthesia and conscious sedation with a combination of a sedative and anesthetic drug during a surgical procedure is an approach designed to avoid intubation, which produces fewer adverse events compared to general anesthesia. In the present study, a comparison was made between the efficacy and safety of remimazolam besylate and propofol for facial plastic surgery. OBJECTIVES: The objective was to evaluate the clinical efficacy, comfort, and incidence of adverse events of remimazolam compared with propofol combined with alfentanil in outpatient facial plastic surgery. METHODS: In this randomized, single-blind, single-center, comparative study, facial plastic surgery patients were randomly divided into remimazolam-alfentanil (n = 50) and propofol-alfentanil (n = 50) groups for sedation and analgesia. The primary endpoint was the incidence of hypoxemia, while secondary endpoints included efficacy and safety evaluations. RESULTS: There were no significant differences regarding the surgical procedure, sedation and induction times, pain and comfort scores, muscle strength recovery, heart rate, respiratory rate, and blood pressure, but the dosage of alfentanil administered to the remimazolam group (387.5 µg) was lower than that for the propofol group (600 µg). The incidence of hypoxemia (P = .046) and towing of the mandibular (P = .028), as well as wake-up (P = .027) and injection pain (P = .008), were significantly higher in the propofol group than the remimazolam group. CONCLUSIONS: Remimazolam and propofol had similar efficacies for sedation and analgesia during facial plastic surgery, but especially the incidence of respiratory depression was significantly lower in patients given remimazolam.


Subject(s)
Alfentanil , Face , Propofol , Humans , Single-Blind Method , Female , Adult , Male , Propofol/administration & dosage , Propofol/adverse effects , Middle Aged , Alfentanil/administration & dosage , Alfentanil/adverse effects , Face/surgery , Benzodiazepines/adverse effects , Benzodiazepines/administration & dosage , Hypnotics and Sedatives/administration & dosage , Hypnotics and Sedatives/adverse effects , Young Adult , Plastic Surgery Procedures/adverse effects , Plastic Surgery Procedures/methods , Anesthetics, Intravenous/administration & dosage , Anesthetics, Intravenous/adverse effects , Treatment Outcome , Hypoxia/etiology , Hypoxia/prevention & control , Conscious Sedation/adverse effects , Conscious Sedation/methods , Ambulatory Surgical Procedures/adverse effects , Ambulatory Surgical Procedures/methods
3.
ACS Omega ; 5(48): 30980-30988, 2020 Dec 08.
Article in English | MEDLINE | ID: mdl-33324806

ABSTRACT

A ternary photocatalyst, Fe3O4-loaded g-C3N4/C-layered composite (g-C3N4/C/Fe3O4) was fabricated by a facile sonication and in situ precipitation technique. Carbon nanosheets were prepared using the remaining non-metallic components of waste printed circuit boards as carbon sources. In this hybrid structure, g-C3N4 was immobilized on the surfaces of carbon nanosheets to form a layered composite, and 10-15 nm Fe3O4 nanoparticles are uniformly deposited on the surface of the composite material. The photocatalytic performance of the catalyst was studied by degrading tetracycline (TC) under simulated sunlight. The results showed that the photoactivity of the g-C3N4/C/Fe3O4 composite to TC was significantly enhanced, and the degradation rate was 10.07 times higher than that of pure g-C3N4, which was attributed to Fe3O4 nanoparticles and carbon nanosheets. Carbon sheets with good conductivity are an excellent electron transporter, which promotes the separation of photogenerated carriers and the Fe3O4 nanoparticles can utilize electrons effectively as a center of oxidation-reduction. Moreover, a possible photocatalytic mechanism for the excellent photocatalytic performance was proposed.

4.
J Hazard Mater ; 394: 121832, 2020 07 15.
Article in English | MEDLINE | ID: mdl-32336537

ABSTRACT

The triadic composite of ZnO/CdO heterojunction decorated with reduced graphene oxide (rGO) was prepared using a one-step hydrothermal method. The characterizations of morphology, structure and composition to the composite were undertaken by XRD, Raman, SEM, TEM, XPS, UV-vis spectra. The sensing experimental data indicate that the highest response of the ZnO/CdO/rGO (1.0 wt%) composite to ppm-level NO2 is 8 times and 2 times higher than pure ZnO and ZnO/CdO junction, respectively. The composite not only exhibits fast response time and recovery time, high response, but also reveals outstanding stability and repeatability at an operating temperature of 125 °C. The sensing mechanism also has been discussed in detail in the work. The enhancement in gas sensing properties is credited to the development of ZnO/CdO heterojunction and the decoration of rGO with high conductivity. The logarithm of sensitivity in the range of 0.4-2.4 ppm NO2 shows good linear dependence, indicating that the composite based sensor can be used to quantificationally detect low concentration of NO2.

5.
Reprod Sci ; 26(2): 233-243, 2019 02.
Article in English | MEDLINE | ID: mdl-29661100

ABSTRACT

Our previous study showed that progesterone (P4) can specifically regulate the expression of some microRNAs (miRNAs) in endometrial epithelium. In the present study, we verified the P4-dependent expression of miR-145/miR-143 in endometrial epithelial cells, explored the regulative mechanism of the P4 receptor (PR), and investigated their effects on the proliferation of endometrial epithelial cells. Our results showed that P4 can induce the expression of miR-145/143 in endometrial epithelial cells by acting on the PR A subtype. P4-induced miR-145/143 can inhibit the expression of cyclin D2 by binding to cyclin D2 mRNA 3'UTR. It can also inhibit cell proliferation in mouse endometrial epithelium by arresting the cell cycle during the G1-S checkpoint. Furthermore, miR-145 and miR-143 can inhibit the proliferation of human endometrial cancer cells. In conclusion, P4-induced miR-145/miR-143 is an important regulator in the proliferation of endometrial epithelial cells, and it can also inhibit the proliferation of human endometrial cancer cells. Our study indicates miRNAs are important mechanism of P4 in inhibiting the proliferation of endometrial epithelial cells. And these miRNAs are potential candidates for the diagnosis of endometrial cancer and therapeutic targets.


Subject(s)
Cell Proliferation/drug effects , Endometrium/drug effects , Epithelial Cells/drug effects , MicroRNAs/metabolism , Progesterone/pharmacology , Animals , Cell Cycle , Cell Line, Tumor , Endometrium/cytology , Endometrium/metabolism , Epithelial Cells/cytology , Epithelial Cells/metabolism , Estradiol/pharmacology , Female , Gene Expression Regulation/drug effects , Mice , MicroRNAs/genetics , Mifepristone/pharmacology
6.
ACS Appl Mater Interfaces ; 10(50): 44092-44101, 2018 Dec 19.
Article in English | MEDLINE | ID: mdl-30474965

ABSTRACT

Thermoresponsive surfaces featured with nanostructures have found wide potential applications in biological and chemical fields. Herein, we report nanostructured thermoresponsive surfaces engineered via stable immobilization of thermoresponsive nanogels with the assistance of polydopamine. The results show that the thin layer of polydopamine on the poly( N-isopropylacrylamide) (PNIPAM) nanogels nearly does not affect the thermoresponsive property of the nanogels. The stability of the thermoresponsive nanogels on the substrate surfaces immobilized under different pH conditions of dopamine solutions are quatitively studied by fluid shearing experiments inside capillaries, and the characterization results show that the strong interaction forces between the polydopamine layer on the substrate surfaces and the thermoresponsive nanogels are heavily dependent on the oxidation state of the dopamine molecules. With the proposed strategy, thermoresponsive nanostructured surfaces immobilized with PNIPAM nanogels on two-dimensional and three-dimensional substrate surfaces are generated to achieve smart cell culture plates and smart gating membranes, respectively, which demonstrate versatile applications of the nanostructured thermoresponsive surfaces.

7.
RSC Adv ; 8(44): 24906-24912, 2018 Jul 09.
Article in English | MEDLINE | ID: mdl-35542146

ABSTRACT

In this study, a simple and rapid polymer monolith microextraction procedure was developed for the determination of Cr(iii) ions by inductively coupled plasma-atomic emission spectrometry. A monolithic column modified with cysteine was synthesized and characterized by scanning electron microscopy, Fourier-transform infrared spectroscopy, X-ray photoelectron spectroscopy, thermal gravimetric analysis, specific surface area analysis and pore size distribution analysis. The influences of analytical parameters such as sample pH, adsorption time, eluent type, and coexisting ions were examined. The limit of detection (LOD) and limit of quantification (LOQ) for Cr(iii) ions were 0.005 µg mL-1 and 0.017 µg mL-1, and the relative standard deviation (RSD) was 7.4% (n = 5). The prepared cysteine functionalized monolithic column displayed good enrichment capacity and was successfully applied to the determination of Cr(iii) ions in real samples.

8.
Reprod Sci ; 24(10): 1444-1453, 2017 10.
Article in English | MEDLINE | ID: mdl-28122483

ABSTRACT

Progesterone (P4) is an important ovarian hormone that inhibits estrogen-dependent proliferation of endometrial epithelial cells (EECs). miR-152 has been reported to be a cell cycle regulator. In this study, we first demonstrated that P4 induced the expression of miR-152 in ovariectomized mice and Ishikawa cell. miR-152 was detected in the human endometrial cell lines that were stably transfected with P4 receptor. Results showed that P4 induced its expression through its receptor B subtype. Then, using the specific miRNA mimic and inhibitor, we proved that miR-152 impeded G1/S transition in the cell cycle of EECs and inhibited cellular proliferation via downregulating WNT-1 in mice and human endometrial cancer cell lines (Ishikawa, HEC-1-b, and KLE). miR-152 induced by P4 is an important inhibitor for the proliferation of EECs. miR-152 may be an important tumor suppressor microRNA in endometrial cancer.


Subject(s)
Cell Proliferation/drug effects , Down-Regulation/drug effects , Endometrium/drug effects , Epithelial Cells/drug effects , MicroRNAs/metabolism , Progesterone/pharmacology , Wnt1 Protein/metabolism , Animals , Cell Count , Cell Line, Tumor , Endometrium/metabolism , Epithelial Cells/metabolism , Estradiol/pharmacology , Female , Humans , Mice , MicroRNAs/genetics , Signal Transduction/drug effects , Wnt1 Protein/genetics
9.
Sheng Li Xue Bao ; 68(6): 716-724, 2016 Dec 25.
Article in Chinese | MEDLINE | ID: mdl-28004065

ABSTRACT

The aim of the present study was to investigate the effects of progesterone (P4)-induced microRNA-1a (miR-1a) on the proliferation of endometrial epithelial cells (EECs) and the underlying mechanism. In vivo, following subcutaneous injection of estradiol (E2) alone (E2 group) or combined injections of E2 and P4 (E2P4 group) in ovariectomized mice, quantitative real-time PCR (qPCR) was used to check the expression of miR-1a-3p in the directly isolated mouse EECs. The agomir or antagomir specific for miR-1a-3p was injected into one side of the uterine horns of ovariectomized mice pretreated with E2 alone or in combination with P4, and the non-specific control agomir or antagomir was injected into their contralateral horns. Flow cytometry was used to analyze the cell cycle of EECs. Immunohistochemistry (IHC) was used to examine the location and expression of cyclin D2, cyclin E1, and cyclin E2 in the uterine tissue sections. In vitro, primary cultured mouse EECs were pretreated with E2 alone (E2 group) or in combination with P4 (E2P4 group). qPCR was used to detect the expression of miR-1a-3p. Exogenous mimic of miR-1a-3p was transfected into E2-pretreated EECs, and EdU incorporation analysis was used to test the proliferation activity of the EECs. The result of in vivo experiment showed that the expression of miR-1a-3p in E2P4 group was significantly higher than that in E2 group (P < 0.05). The miR-1a-3p agomir arrested cell cycle at G1 to S transition in the mice injected subcutaneously with E2 alone (P < 0.05). Conversely, silencing of miR-1a-3p with transfection of miR-1a-3p antagomir promoted the entry of cells into S phase in the mice injected subcutaneously with both E2 and P4 (P < 0.05). The expressions of cyclin E1 and cyclin E2, except for cyclin D2, in uterine sections were also dramatically reduced by miR-1a-3p overexpression in the uterine epithelium (P < 0.05). In vitro, miR-1a-3p was not expressed in the cells of both E2 and E2P4 groups. The mimic of miR-1a-3p decreased EECs proliferation activity (P < 0.05). These results indicate that P4-induced miR-1a can inhibit the expression of cyclin E1 and cyclin E2, consequently suppressing the proliferation of mouse EECs by arresting cells at G1/S phase.


Subject(s)
Cell Proliferation , Epithelial Cells , Uterus , Animals , Cell Cycle , Cell Division , Cells, Cultured , Estradiol , Female , Mice , MicroRNAs , Progesterone , Real-Time Polymerase Chain Reaction , Transfection
10.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 47(2): 147-51, 2016 Mar.
Article in Chinese | MEDLINE | ID: mdl-27263284

ABSTRACT

OBJECTIVE: To determine the expression of microRNA-152 induced by progesterone and its effect on the proliferation of endometrial epithelial cells (EECs). METHODS: Cultured EECs, Ishikawa were divided into four groups: control group (C group), 10(-8) mol/L estrogen treated group (E group), 10(-6) mol/L progesterone group (P group) and estrogen plus progesterone treated group (E&P group). The expression of mature microRNA-152 (microRNA-152-3p) of was detected by qRT-PCR. The estrogen treated cells were transfected with mimic-microRNA-152-3p. The estrogen and progesterone treated cells were transfected with inhibitor-microRNA-152-3p. Cell proliferations were detected by CCK-8 assay. The target gene of microRNA-152-3p proteins was predicted using microRNA target databases and validated by Western blot. RESULTS: qRT-PCR showed no difference between C and E groups (P > 0.05) in the expression of microRNA-152-3p. P group had higher expressions of microRNA-152-3p than C group (P < 0.05). E&P group had higher expressions of microRNA-152-3p than C group and P group. MicroRNA target protein prediction suggested that CDC14A is one of direct target proteins of microRNA-152-3p. The results of CCK-8 assay showed that mimic-microRNA-152-3p transfection blocked proliferations of estrogen treated cells and lowered expressions of CDC14A in these cells; while inhibitor-microRNA-152-3p promotes proliferations of estrogen and progesterone treated cells and increased expressions of CDC14A in these cells. CONCLUSION: Progesterone may suppress proliferations of EECs through inducing expressions of microRNA-152-3p. CDC14A is probably one target protein of microRNA-152-3p for its action on EECs.


Subject(s)
Epithelial Cells/cytology , MicroRNAs/metabolism , Progesterone/pharmacology , Blotting, Western , Cell Proliferation , Cells, Cultured , Estrogens/pharmacology , Humans , Transfection
11.
Reprod Sci ; 22(2): 223-34, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24925854

ABSTRACT

In endometrial epithelial cells, progesterone (P4) functions in regulating the cell structure and opposing the effects of estrogen. However, the mechanisms of P4 that oppose the effects of estrogen remain unclear. MicroRNAs (miRNAs) are important posttranscriptional regulators that are involved in various physiological and pathological processes. Whether P4 directly induces miRNA expression to antagonize estrogen in endometrial epithelium is unclear. In this study, total RNAs were extracted from endometrial epithelium of ovariectomized mice, which were treated with estrogen alone or a combination of estrogen and P4. MicroRNA high-throughput sequencing with bioinformatics analysis was used to identify P4-induced miRNAs, predict their potential target genes, and analyze their possible biological functions. We observed that 146 mature miRNAs in endometrial epithelial cells were significantly upregulated by P4. These miRNAs were extensively involved in multiple biological processes. The miRNA-145a demonstrated a possible function in the antiproliferative action of P4 on endometrial epithelial cells.


Subject(s)
Endometrium/drug effects , Epithelial Cells/drug effects , Estrogens/pharmacology , MicroRNAs/metabolism , Progesterone/pharmacology , Animals , Cell Proliferation/genetics , Computational Biology , Endometrium/metabolism , Epithelial Cells/metabolism , Female , Gene Expression Profiling , Gene Expression Regulation , Gene Library , Gene Regulatory Networks , High-Throughput Nucleotide Sequencing , Mice , MicroRNAs/genetics , Oligonucleotides/administration & dosage , Ovariectomy , Real-Time Polymerase Chain Reaction , Reproducibility of Results , Reverse Transcriptase Polymerase Chain Reaction
12.
Dev Comp Immunol ; 46(2): 508-17, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24968076

ABSTRACT

The lysozymes identified so far in animals belong to the g-type, c-type, and i-type. Vertebrate animals possess only the former two types, i.e., g- and c-types, while all the three types have been reported in invertebrates. Here we demonstrate that (1) three cDNAs that encode g-, c-, and i-type lysozymes, respectively, were identified in a single species of the amphioxus Branchiostoma japonicum; (2) all the 3-type genes displayed distinct tissue-specific expression pattern; (3) recombinant g-, c-, and i-type lysozymes all exhibited enzymatic activities; and (4) native g-, c-, and i-type lysozymes were identified in the different tissues of amphioxus. Collectively, these results suggest the presence of all the 3-type lysozymes in a single animal species, first such data ever reported. The presence of biologically active i-type lysozyme in amphioxus also suggests that i-type lysozyme gene is retained at least in Protochordata, contrasting to the previous proposal that i-type lysozyme gene has been lost in a common ancestor of all chordates.


Subject(s)
Lancelets/enzymology , Muramidase/genetics , Animals , Catalytic Domain , Gene Expression , Hydrogen-Ion Concentration , Lancelets/genetics , Models, Molecular , Muramidase/biosynthesis , Muramidase/chemistry , Organ Specificity , Phylogeny , Protein Structure, Secondary
13.
Mol Immunol ; 49(1-2): 211-8, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21908048

ABSTRACT

Vitellogenin (Vg), once reported to be a female-specific protein, has been identified in both male and juvenile fishes. However, the biological significance of the production of Vg in the male and juvenile fishes is elusive. Our previous studies showed that Vg is an opsonin capable of enhancing phagocytosis, but the mechanism by which Vg mediates phagocytosis is unknown. In this study we demonstrated that Vg-opsonized phagocytosis was characterized by pseudopod extension and depended upon tyrosine kinase. In contrast, inhibition of Rho family proteins and microtubule depolymerization had little effects on Vg-opsonized phagocytosis. Besides, Vg-opsonized phagocytosis was substantially blocked by monoclonal antibodies against FcγRs but not by CR3 antibody. Moreover, theoretical prediction analysis further revealed that Vg had the potency to interact with Fcγ receptors. Finally, the expression of proinflammatory cytokine genes tnf-α and il-1ß was significantly up-regulated by Vg, and this up-regulation was inhibited by selective inhibitors of FcR signaling pathways, wortmannin and piceatannol. Taken together, these results suggest that Vg plays an IgG-like role in that it activates FcγR-mediated phagocytosis, thus establishing an antibody-like function for Vg for the first time.


Subject(s)
Bass/immunology , Fish Proteins/immunology , Phagocytosis/immunology , Receptors, IgG/immunology , Vitellogenins/immunology , Animals , Female , Fish Proteins/metabolism , Macrophages/immunology , Macrophages/metabolism , Male , Real-Time Polymerase Chain Reaction , Receptors, IgG/metabolism , Vitellogenins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...